BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Prilenia Therapeutics B.V.

Headquarters: Naarden, Netherlands
Year Founded: 2018
Status: Private

BioCentury | Sep 19, 2024
Management Tracks

EMA names Sepodes CHMP chair, Bell leaving Valo as CEO, and more

Plus: Autolus hires Matthias Will as CDO, and updates from HotSpot, Prilenia, Frazier, BIA and BioCentriq
BioCentury | May 30, 2024
Finance

Venture Report: Canadian VC Amplitude closes new fund; CinRx’s series C

Plus: Adcendo’s series A is again Denmark’s largest; VCs and foundations back Lucy
BioCentury | Apr 4, 2024
Management Tracks

Upstream names new CEO, CFO and COO

Plus: Acadia hires Elizabeth Thompson as head of R&D, and updates from Insitro, Fractyl, Adarx and more
BioCentury | Feb 24, 2023
Regulation

Feb. 23 Quick Takes: FDA approves Sanofi’s once-weekly hemophilia A therapy

Plus: CMS stays the course on Alzheimer's NCD and updates from Blueprint, Apellis, AZ, Nektar, Keymed, Prilenia and more  
BioCentury | Nov 2, 2022
Emerging Company Profile

ProJenX: protecting neurons to treat ALS

Project ALS and Medical Excellence-backed company hopes to take same regulatory path forged by Amylyx
BioCentury | Sep 30, 2022
Management Tracks

Sullivan becomes CBO at Prilenia 

Plus new CMO at Cellectis, and updates from Lyell, Adrestia, Mursla and more
BioCentury | Apr 13, 2022
Product Development

April 12 Quick Takes: FDA lifts clinical hold on magrolimab studies

Plus: Setback for Myovant at FDA and updates from Takeda, Ocugen, Prilenia, AbbVie and more
BioCentury | Apr 1, 2022
Management Tracks

Morgan Stanley’s Christine Ha becomes CFO at Ventus

Plus new CEO at Zealand Pharma, updates from Nuvalent, Pathalys and more
BioCentury | Jan 21, 2022
Data Byte

State of the Huntington’s disease pipeline

Setbacks for HTT-targeting programs have put alternative therapeutic approaches out in front
BioCentury | Nov 4, 2021
Product Development

Nov. 3 Quick Takes: Flagship, CF Foundation forming start-up

Plus Antios raises, Novo Nordisk misses, GRObio, Prilenia and more
Items per page:
1 - 10 of 13
Help Center
Username
Request a Demo
Request Training
Ask a Question